As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 1/25/12  Kirk Randal J                     SC 13D/A               2:105K Alaunos Therapeutics, Inc.        Broadridge Fin’l So… Inc 
          Intrexon Corp.³
 1/25/12  Alaunos Therapeutics, Inc.        8-K:1,8,9   1/20/12    4:264K                                   Toppan Merrill/FA        

____________
¹	Filing/Form Types:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.